StemGenex Surgery Center Receives Nationally-Respected AccreditationApril 10, 2018
We’re honored to announce that StemGenex Stem Cell Research Centre, which spans 7,800 square feet, has confirmed accreditation from the Accreditation Association for Ambulatory Health Care (AAAHC) for its state-of-the-art Pacific Coast Surgical Center.
The AAAHC accreditation assures patients that our organization meets or exceeds nationally-recognized standards and distinguishes our facility by providing the highest quality of care and safety to our patients.
Known as the accreditor of choice in the United States, the AAAHC accreditation is recognized by the federal government and accredits a variety of organizations including surgery centers, military and university health clinics and large medical practices.
We are proud to assure that patients receive the highest quality of patient care, in adherence to nationally accepted standards, by participating in on-site surveys, undergoing external independent health care reviews, and receiving on-going evaluations by AAAHC health professionals.
AAAHC currently accredits more than 6,000 organizations in a wide variety of ambulatory health care settings including ambulatory surgery centers, community health centers, medical and dental group practices, medical home practices, and managed care organizations, as well as Indian and student health centers, among others. AAAHC is also the official accrediting organization for the US Coast Guard. With a single focus on the ambulatory care community, AAAHC offers organizations a cost-effective, flexible, and collaborative approach to accreditation.
ABOUT StemGenex Stem Cell Research Centre
StemGenex Stem Cell Research Centre is committed to helping people achieve optimum health and better quality of life through the healing benefits of their own stem cells. StemGenex provides access to adult stem cell therapy for individuals suffering with inflammatory and degenerative illnesses. Committed to the science and innovation of stem cell treatment, StemGenex sponsors five clinical outcome studies registered with the National Institutes of Health (NIH) for Multiple Sclerosis, Parkinson’s Disease, Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease (COPD) and Osteoarthritis. These have been established to formally document and evaluate the quality of life changes in individuals following adipose-derived stem cell treatment.
To find out if you are a candidate for stem cell treatment, Call (855) 742-7836 to speak with a Patient Advocate or Visit www.stemgenex.com.